These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 14374869)

  • 1. [Manifestations of mesantoin reactions].
    LEIBETSEDER F; ZELGER J
    Z Haut Geschlechtskr; 1954 Dec; 17(11):337-42. PubMed ID: 14374869
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complications in mesantoin therapy of epilepsy].
    ANDERSSON B
    Sven Lakartidn; 1953 Feb; 50(9):482-4. PubMed ID: 13077237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental production of lymph node swellings by feeding of mesantoin].
    KASLARIS E
    Wien Klin Wochenschr; 1953 Dec; 65(50):1007-8. PubMed ID: 13147158
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lymph node swellings after mesantoin medication and their cytological picture].
    BODART F
    Wien Z Inn Med; 1953 Oct; 34(10):375-9. PubMed ID: 13137057
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fatal pancytopenia caused by mesantoin therapy].
    KOSKINEN P
    Duodecim; 1953; 69(7-8):644-7. PubMed ID: 13107579
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mesantoin and severe bone marrow aplasias].
    HOLTEN C
    Ugeskr Laeger; 1954 Feb; 116(7):256-7. PubMed ID: 13146896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mesantoin injury and infectious mononucleosis].
    IPPEN H
    Dtsch Med Wochenschr; 1959 Apr; 84(14):683-6. PubMed ID: 13639711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute nephrotic syndrome caused by mesantoin treatment].
    HOFLE KH; SCHOOP W
    Dtsch Med Wochenschr; 1959 Apr; 84(17):837-8. PubMed ID: 13652662
    [No Abstract]   [Full Text] [Related]  

  • 9. [Regular blood counts after treatment with mesantoin & dimedione].
    KIORBOE E; KROMANN K
    Nord Med; 1958 Nov; 60(45):1599-602. PubMed ID: 13613564
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal pancytopenia as a result of improperly supervised mesantoin therapy.
    BURRELL ZL
    Am Pract Dig Treat; 1955 May; 6(5):726-8. PubMed ID: 14361960
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukopenia and scarlatiniform exanthema resulting from medication with mesantoin.
    BJØRNSTAD R
    Acta Derm Venereol; 1953; 33(5):425-7. PubMed ID: 13113826
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesantoin and pulmonary changes.
    Goffman TE; Dicicco BS; Tsou E
    Ann Intern Med; 1982 Feb; 96(2):254-5. PubMed ID: 7059081
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mesantoin side-effects with Addison pigmentation and cerebral seizure rhythm].
    Gottwald W; Aksoy F
    Hautarzt; 1965 Oct; 16(10):445-9. PubMed ID: 5866254
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of epilepsy with mesantoin and phenantoin.
    LUND M; NØRGAARD K
    Acta Psychiatr Neurol Scand Suppl; 1951; 74():118-9. PubMed ID: 14902557
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic demethylation of 3-methyl-5-ethyl-5-phenyl hydantoin (Mesantoin).
    BUTLER TC
    J Pharmacol Exp Ther; 1952 Mar; 104(3):299-308. PubMed ID: 14908899
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with mesantoin].
    DREYER R
    Dtsch Med Wochenschr; 1954 Aug; 79(33-34):1215-8. PubMed ID: 13200204
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with new anticonvulsants similar to mesantoin (N3, N5 and N7)].
    SCHWEINGRUBER R; KETZ E
    Schweiz Med Wochenschr; 1962 May; 92():651-4. PubMed ID: 14039092
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myxedematous complications occurring during dimethyldithiohydantoin therapy].
    DONNADIEU A; DE BOUCAUD P; SCHNETZLER JP; FOURNIAL P
    J Med Bord; 1955 Jan; 132(1):32-7. PubMed ID: 14354386
    [No Abstract]   [Full Text] [Related]  

  • 19. [Special forms and courses of exanthems caused by drugs].
    PIPER HG
    Dermatol Wochenschr; 1957 Aug; 136(33):880-8. PubMed ID: 13473411
    [No Abstract]   [Full Text] [Related]  

  • 20. Agranulocytosis-iatrogenic disease.
    CALLAHAN D; BURRELL ZL
    Am Pract Dig Treat; 1957 Nov; 8(11):1766-70. PubMed ID: 13470300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.